相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role
B. Smith et al.
GYNECOLOGIC ONCOLOGY (2016)
A novel truncated form of HMGA2 in tumors of the ovaries
Antonio Agostini et al.
ONCOLOGY LETTERS (2016)
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
Salveena Schiffgens et al.
ONCOTARGET (2016)
Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
Seiya Yokoyama et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
Giulio Cabrini et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients
Tao Huang et al.
SCIENTIFIC REPORTS (2015)
Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients
Stefano Pierini et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area
Adfar Yousuf et al.
CELLULAR ONCOLOGY (2014)
A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the O6-Methylguanine-DNA Methyltransferase Promoter
Daniel Hochhauser et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
Mariana Brait et al.
PLOS ONE (2013)
DNA methylation data analysis and its application to cancer research
Xiaotu Ma et al.
EPIGENOMICS (2013)
DNA Methylation Pattern as Important Epigenetic Criterion in Cancer
Mehrdad Ghavifekr Fakhr et al.
GENETICS RESEARCH INTERNATIONAL (2013)
Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics
Simon Kaja et al.
JOURNAL OF BIOMEDICAL OPTICS (2012)
Inactivation of O6-methyguanine-DNA methyltransferase by promoter hypermethylation: Association of epithelial ovarian carcinogenesis in specific histological types
Hyun-Jin Roh et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified
Michael D. Coory
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
Russell Vang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
Parvesh Chaudhry et al.
CANCER INVESTIGATION (2009)
Absence of MGMT promoter methylation in endometrial cancer
B. J. Rimel et al.
GYNECOLOGIC ONCOLOGY (2009)
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: Comparison with methylation-specific PCR technique and clinical significance
Eung-Seok Lee et al.
CLINICAL CANCER RESEARCH (2008)
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Qinghua Wu et al.
MOLECULAR CANCER (2007)
The high frequency of De novo promoter methylation in synchronous primary endometrial and ovarian carcinomas
Daniela Furlan et al.
CLINICAL CANCER RESEARCH (2006)
Promoter hypermethylation profile of ovarian epithelial neoplasms
PB Makarla et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
